GlassScriptPhysician profile
Jason Henry
NPI 1235541673
$1,378.49
in general payments reported to CMS, 2019-2025
15 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what 79% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $97.97 · 2022: $47.10 · 2023: $61.81 · 2024: $22.78 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900 · Travel and Lodging: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.35 |
| Travel and Lodging | $333.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $358.49 | 2020-2025 | Nucala, Trelegy Ellipta |
| Cook Medical LLC | $333.07 | 2025 | Blue Rhino |
| Astrazeneca Pharmaceuticals LP | $132.97 | 2020-2025 | Fasenra, Airsupra, Tezspire |
| Genzyme Corporation | $116.51 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $103.48 | 2020-2025 | Dupixent |
| Intuitive Surgical, INC. | $57.10 | 2022-2023 | Da Vinci Surgical System |
| Viatris Specialty LLC | $50.48 | 2025 | Yupelri |
| Grifols USA, LLC | $45.31 | 2024-2025 | Prolastin-C Liquid |
| Biogen, INC. | $39.97 | 2025 | Tysabri, Vumerity |
| Tg Therapeutics, INC. | $33.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $31.16 | 2020 | |
| Merck Sharp & Dohme LLC | $28.66 | 2025 | Keytruda |
| Insmed, INC. | $25.12 | 2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.54 | 2025 | Ofev |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.